The size of the Europe Biopreservation Market was worth USD 1163.00 million in 2021 and will worth USD 2063.36 million by 2026, with a compound annual growth rate (CAGR) of 12.15%.
Biopreservation has gained significance in recent years with the rising prevalence of chronic diseases. It is also increasingly adopted by the life sciences companies to develop tissue or a cell-related therapies. With the increasing spending on healthcare and rising demand for novel-preservatives techniques, the biopreservation market is expected to witness growth.
Through biopreservation, biological samples are stored in an environment suitable for their survival. Biological samples that are stored through biopreservation typically include cells, plasma, tissues, saliva, organs and body fluids. Biobanks are leaning towards software tools and automated systems to improve management, storage and retrieval of HBS without sacrificing sample integrity and sustainability. With the growing volumes of human biological samples to be preserved, the storage space must be utilized efficiently.
Increasing expenditure of healthcare, increased population opting for preserving newborn stem cells, rising R&D expenditure on drug discovery and biobanks, government and corporate organizations investments are the major factors contributing to the growth of the market. Advances in the diagnostics and personalized medicines and increasing applications of biopreservation are also aiding the growth of the market.
However, high costs and issues pertaining to the stability of specimens are restraining the growth of the market.
This research report on the European Biopreservation Market has been segmented and sub-segmented into the following categories:
By Product Type:
By Bio samples:
By Application:
By end-users:
By Country:
Notable companies operating in European Biopreservation Market are Thermo Fisher Scientific, Inc, BioLife Solutions, Inc, Sigma-Aldrich Corporation, VWR Corporation, BioCision LLC, Cesca Therapeutics Inc, So-Low Environmental Equipment Co, Taylor-Wharton, Panasonic Corporation and Lifeline Scientific Inc.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 By Product Type
5.1.1 Biopreservation Media
5.1.2 Biopreservation equipment
5.1.3 Lab Information System Management
5.2 By Bio-Specimens
5.2.1 Human tissue samples
5.2.2 Organs
5.2.3 Stem cells
5.2.4 Other bio-specimens
5.3 By Application
5.3.1 Therapeutic applications
5.3.2 Research applications
5.3.3 Clinical trials
5.3.4 Other applications
5.4 By End-User
5.4.1 Biobanks
5.4.2 Gene Banks
5.4.3 Hospitals
5.4.4 Others
6. Geographical Analysis
6.1 Introduction
6.2 U.K
6.3 Spain
6.4 Germany
6.5 Italy
6.6 France
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1BioLife Solutions
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Thermo Fisher Scientific
8.3 Sigma-Aldrich Corporation
8.4 BioCision LLC
8.5 VWR Corporation
8.6 Cesca Therapeutics
8.7 Taylor-Wharton
8.8 So-Low Environmental Equipment
8.9 Panasonic Corporation
8.10 Lifeline Scientific
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Apr 2021
